Tag: Roche
Roche Discontinues Huntington’s Gene-Silencing Program Amid Competitive Pressures
Roche has discontinued its Huntington's disease gene-silencing program, highlighting competitive pressures in neurodegenerative therapeutics. The decision comes as ARPA-H launches…
Submit Your Paper to GMJ
No APC until January 2027.